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o r i g i n a l a r t i c l e
Multicenter Evaluation of Computer Automated versus Traditional
Surveillance of Hospital-Acquired Bloodstream Infections
Michael Y. Lin, MD, MPH;1 Keith F. Woeltje, MD, PhD;2 Yosef M. Khan, MBBS, MPH, PhD;3,a Bala Hota, MD, MPH;1,4
Joshua A. Doherty, BS;2 Tara B. Borlawsky, MA;3 Kurt B. Stevenson, MD, MPH;3 Scott K. Fridkin, MD;5
Robert A. Weinstein, MD;1,4 William E. Trick, MD;1,4
for the Centers for Disease Control and Prevention Epicenter Program
objective. Central line–associated bloodstream infection (BSI) rates are a key quality metric for comparing hospital quality and safety.
Traditional BSI surveillance may be limited by interrater variability. We assessed whether a computer-automated method of central line–
associated BSI detection can improve the validity of surveillance.
design. Retrospective cohort study.
setting. Eight medical and surgical intensive care units (ICUs) in 4 academic medical centers.
methods. Traditional surveillance (by hospital staff) and computer algorithm surveillance were each compared against a retrospective
audit review using a random sample of blood culture episodes during the period 2004–2007 from which an organism was recovered.
Episode-level agreement with audit review was measured with k statistics, and differences were assessed using the test of equal k coefficients.
Linear regression was used to assess the relationship between surveillance performance (k) and surveillance-reported BSI rates (BSIs per
1,000 central line–days).
results. We evaluated 664 blood culture episodes. Agreement with audit review was significantly lower for traditional surveillance (k
[95% confidence interval [0.37–0.51]) than computer algorithm surveillance (k [95% [0.52–0.64]; ).(CI)] p 0.44 CI] p 0.58 P p .001
Agreement between traditional surveillance and audit review was heterogeneous across ICUs ( ); furthermore, traditional surveillanceP p .01
performed worse among ICUs reporting lower (better) BSI rates ( ). In contrast, computer algorithm performance was consistentP p .001
across ICUs and across the range of computer-reported central line–associated BSI rates.
conclusions. Compared with traditional surveillance of bloodstream infections, computer automated surveillance improves accuracy
and reliability, making interfacility performance comparisons more valid.
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Affiliations: 1. Department of Medicine, Rush University Medical Center, Chicago, Illinois; 2. Department of Medicine, Washington University School
of Medicine, St Louis, Missouri; 3. Department of Medicine, Ohio State University Medical Center, Columbus, Ohio; 4. Department of Medicine, Cook
County Health and Hospitals System, Chicago, Illinois; 5. Centers for Disease Control and Prevention, Atlanta, Georgia; a. Present affiliation: Division of
Quality and Health Information Technology, American Heart Association–National Center, Dallas Texas.
Received May 16, 2014; accepted August 5, 2014; electronically published November 10, 2014.
The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control
and Prevention or the Agency for Toxic Substances and Disease Registry.
 2014 by The Society for Healthcare Epidemiology of America. All rights reserved. 0899-823X/2014/3512-0007$15.00. DOI: 10.1086/678602
Hospital-acquired central line–associated bloodstream infec-
tions (BSIs) commonly lead to adverse patient outcomes and
are largely preventable.1,2 Central line–associated BSI rates,
which are self-reported by hospitals, are perceived as a key
performance measure used to compare patient safety between
institutions.3 In 2012, the Center for Medicare and Medicaid
Services (CMS) began reporting central line–associated BSI
rates on its Hospital Compare website (http://www
.medicare.gov/hospitalcompare) to facilitate public transpar-
ency with BSI rates and with the intention of levying future
payment reductions for those hospitals reporting poorer rates
(ie, pay for performance).4,5
Traditional surveillance of central line–associated BSIs uses
standard case definitions and operational methodology, such
as those supported by the Centers for Disease Control and
Prevention (CDC) National Healthcare Safety Network
(NHSN).6 Trained hospital staff (infection preventionists) in-
terpret clinical events to judge whether certain rules for BSI
are satisfied, such as whether a blood culture pathogen orig-
inated from the bloodstream versus an extravascular source
(ie, a secondary bacteremia).
Earlier studies have detected significant variation in the
performance of traditional BSI surveillance at the individual
infection preventionist level7,8 as well as at a facility level;9
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table 1. National Healthcare Safety Network Definition for Laboratory-Confirmed Bloodstream Infection Used
by Audit Reviewer, 2009–2010
Criterion Definition
1 Patient has a recognized pathogen cultured from at least 1 blood culture, and pathogen cultured from
blood is not related to an infection at another site OR
2 Patient has at least 1 of the following signs or symptoms: fever (temperature, 138C), chills, or hypo-
tension; positive cultures are not related to infection at another site; and common commensala is
cultured from at least 2 blood cultures obtained on separate occasions
note. Central line–associated bloodstream infection is defined as a laboratory-confirmed bloodstream infection
not present or incubating at admission, and the patient has a central line at the time or within 48 hours of the time
that blood culture was obtained.25 Note that the current 2014 central line–associated bloodstream infection definition
uses the same criteria as above, except that a 2-calendar-day rule is used instead of 48 hours.
a Includes Corynebacterium species (diphtheroids), Bacillus species, Propionibacterium species, coagulase-negative
Staphylococcus species, and Micrococcus species.
such variation complicates the comparison of hospitals on
the basis of their publicly reported rates. The CDC has rec-
ommended audit review of BSI surveillance as a primary
method to assess and improve the reliability of central line–
associated BSI reporting at facilities.10
As a proposed alternative to traditional surveillance, au-
tomated computer algorithmic BSI detection11 is objective, is
efficient, and can be implemented identically across multiple
institutions, potentially making interinstitutional rate com-
parisons more reliable.12 Previously, computer algorithm sur-
veillance was shown to have substantial agreement with expert
review at a single institution.13 A multicenter assessment of
computer algorithm surveillance reporting characteristics
through audited review is needed to better compare its per-
formance with that of traditional central line–associated BSI
surveillance.
We performed a multi-institutional comparison of the per-
formance of traditional surveillance versus computer algo-
rithm central line–associated BSI surveillance using a retro-
spective audit review as the comparator. We evaluated
performance at the individual BSI episode level as well as at
the intensive care unit (ICU) level. We hypothesized that
computer algorithm BSI surveillance would have better ac-
curacy and reliability than traditional surveillance. If con-
firmed, such findings could have important implications for
improving the current practice of public reporting and in-
terinstitutional comparison of central line–associated BSI
rates.
methods
This study was conducted at 4 academic medical centers (2
in Chicago, IL; 1 in Columbus, OH; 1 in St Louis, MO). One
medical ICU and 1 surgical ICU from each medical center,
for a total of 8 ICUs, contributed patient data. The study
involved clinical data from January 1, 2004, through June 30,
2007. Retrospective audit review was performed from 2009
to 2010. This study was approved by the institutional review
boards at each participating center.
At all medical centers, blood and other body site cultures
were obtained as a part of usual clinical practice. Blood cul-
tures were processed at each medical center’s microbiology
laboratory using standard automated blood culture detection
systems.
Traditional Surveillance
Data from routine central line–associated BSI surveillance
were produced by infection preventionists at each medical
center using NHSN definitions. All participants in traditional
surveillance were blinded to participation in the study, with
no knowledge of computer algorithm detection. Fifteen in-
fection preventionists participated; all were registered nurses
or microbiologists and had a median of 7 years of infection
control experience (range, 0–30 years). All had received for-
mal central line–associated BSI surveillance training, either
provided by the CDC or by the Association for Professionals
in Infection Control and Epidemiology.
Traditional surveillance was performed using standardized
NHSN surveillance criteria (Table 1). During the study period
(and until 2008), NHSN central line–associated BSI criteria
also included a criterion for infection preventionists to cat-
egorize a single positive blood culture with a common skin
commensal (Corynebacterium species, Bacillus species, Pro-
pionibacterium species, coagulase-negative Staphylococcus spe-
cies, and Micrococcus species) as central line–associated BSI
if clinical symptoms were present, the blood pathogen was
not related to an infection at another site, and appropriate
antimicrobials were prescribed by a physician. After 2008,
this criterion was removed as part of the NHSN definition
of a central line–associated BSI. To make the analysis appli-
cable to post-2008 NHSN surveillance activity, study person-
nel retrospectively reclassified any blood culture episodes con-
taining only a single culture result of a single common skin
commensal as “not central line–associated BSI.” No blood
culture episodes required recoding based on this reclassifi-
cation scheme.
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figure 1. Schematic of computer algorithm adapting National Healthcare Safety Network criteria for central line–associated bloodstream
infection (CLABSI) surveillance. Common skin commensals (CSCs) are defined as diphtheroids, Bacillus species, Propionibacterium species,
coagulase-negative Staphylococcus species, or Micrococcus species. The computer algorithm required recovery of the same common skin
commensal from 2 separate blood cultures within 2 consecutive hospital days in an episode. Calendar date of admission to the hospital
is considered hospital day 1. Active surveillance screening cultures and catheter tip cultures were not considered to avoid misclassifying
episodes as secondary. Central line presence included any duration of use and was assessed on first day of a primary bloodstream infection
episode through 2 hospital days before the episode.
Computer Algorithm Surveillance
A previously validated computer algorithm was used to ap-
proximate NHSN central line–associated BSI surveillance cri-
teria.13 The algorithm retrospectively identified blood culture
episodes that fulfilled algorithmic criteria for central line–
associated BSIs within ICUs at each medical center using data
available from the electronic health record (see Figure 1 for
algorithm steps and data inputs; computer programming
code is available at http://bsi.cchil.org). All 4 medical centers
automated the computer algorithm surveillance, although 3
centers required a preparatory step of manual data abstraction
of central line presence before running the computer pro-
gram. The computer algorithm defined a blood culture ep-
isode as an eligible blood culture plus all subsequent cultures
within a 5-day period; each episode had 1 of the following
possible 4 determinations: “central line–associated BSI,” “pri-
mary bloodstream infection, not central line associated,” “sec-
ondary bloodstream infection,” or “contaminant.”
Sampling for Audit Review and Primary Analysis
For all institutions, to preserve the relative proportion of
available blood culture episodes in each respective ICU type,
we performed stratified random sampling of blood culture
episodes within medical and surgical ICUs. We limited our
sampling on the basis of a quota, such that the number of
blood culture episodes reviewed by the audit reviewer at each
institution was 140. To direct the limited resources of the
audit reviewers toward blood culture episodes with potentially
ambiguous categorization, sampled episodes that were already
categorized as “not central line–associated BSI” by the in-
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table 2. Characteristics of the Random Sample of Blood Culture Episodes
Variable




















Gram positive only 421 (63)
Gram negative only 116 (17)
Fungal only 48 (7)
Other (mixed infection) 79 (12)
Episodes with ≥1 of following species recovereda
Common skin commensal species 347 (52)
Enterococcus species 98 (15)
Enterobacteriaciae 90 (14)
Candida species 77 (12)
Staphylococcus aureus 62 (9)
Pseudomonas aeruginosa 46 (7)
note. ICU, intensive care unit; MICU, medical intensive care unit; SICU,
surgical intensive care unit.
a Episodes can have more than 1 species if polymicrobial; therefore, percentages
may total greater than 100%.
fection preventionist and “contaminant” (specifically, single
common skin commensals) by the computer algorithm were
presumed to have an audit reviewer categorization of “neg-
ative;” these episodes were retained in the final random sam-
ple for analysis but did not count toward the quota at each
institution. Thus, inclusion of these episodes allowed each
center to variably expand its study sample beyond the 140-
episode review quota.
Audit Reviewer
A single infection preventionist from each medical center who
had not previously performed central line–associated BSI sur-
veillance at the study ICUs during the study period performed
a retrospective audit of the sampled blood culture episodes
from the study cohort. The audit reviewers were all registered
nurses with formal central line–associated BSI surveillance
training and 2–9 years of infection control experience. The
audit reviewers additionally received a standardized study ori-
entation and investigator-led training by telephone. To en-
courage adherence to NHSN surveillance criteria, they used
a surveillance worksheet that prompted application of NHSN
central line–associated BSI surveillance criteria (Table 1) in
a step-wise, structured format. The audit reviewers, blinded
to traditional and computer algorithm surveillance deter-
minations, categorized each episode as either “central line–
associated BSI” or “not central line–associated BSI.”
Analysis
We calculated the level of agreement (k statistic) between
traditional surveillance and audit review and between the
computer algorithm and audit review. We used the test of
equal k coefficients to assess for differences in overall k es-
timates as well as to assess for heterogeneity of ICU-specific
k values across study ICUs.
To test for significant differences in k heterogeneity among
study ICUs for traditional surveillance versus computer al-
gorithm surveillance, we calculated the distance from the
mean level of agreement for each ICU compared with the
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figure 2. Distribution of k estimates for traditional surveillance
and computer algorithm surveillance, both compared with audit
review. Solid circles represent k point estimates of individual inten-
sive care units. Diamonds represent summary point estimates. Ver-
tical lines represent 95% confidence intervals of the k estimates.
pooled mean. After confirming that these differences were
normally distributed, we compared the distribution of the
differences using the paired Student t test.
To assess for a relationship between an ICU’s surveillance
performance and its BSI rates, we created a robust linear
regression of each ICU’s k for traditional surveillance/audit
agreement versus its overall central line–associated BSI rate
as determined using traditional surveillance. We similarly cre-
ated a linear regression using the computer algorithm/audit
agreement versus the computer algorithm–determined ICU-
specific central line–associated BSI rate. The central line–
associated BSI rate was defined as the number of central line–
associated BSIs divided by 1,000 central line–days. Central
line–days were obtained from daily counts provided by each
ICU’s nursing unit using CDC methods;6 these counts were
used as denominators to calculate rates for both infection
preventionist and computer algorithm measures of central
line–associated BSI rates. We performed analysis to detect
outliers and violations of model assumptions. For all analyses,
we used Stata (version 10) or SAS (version 9.1.3).
results
Blood Culture Episodes
Among the 8 ICUs, we identified 1,251 blood culture episodes
during the study period; a random sample of 664 episodes
(53% of the total) was selected. Microbiological characteristics
of the random sample of blood culture episodes are presented
in Table 2. Most were monomicrobial; common skin com-
mensals (Bacillus species, coagulase-negative Staphylococcus
species, Corynebacterium species, Micrococcus species, and
Propionibacterium species) were the most common organism
type recovered, followed by Enterococcus species, Enterobac-
teriaceae, Candida species, and Staphylococcus aureus. The
proportion of the study sample categorized as central line–
associated BSI varied by method, as follows: traditional sur-
veillance, 145 (22%); computer algorithm, 266 (40%); and
audit review, 213 (32%).
Comparison of Agreement with Audit Review
The computer algorithm had a significantly higher rate of
agreement with the audit review, compared with that of tra-
ditional surveillance (computer algorithm, k [95% confidence
interval [0.52–0.64]; traditional surveillance,(CI)] p 0.58
); ; Figure 2).k [95% CI] p 0.44 [0.37–0.51] P p .001
Comparison of Variation in Performance
The consistency of central line–associated BSI agreement with
the audit review was better for the computer algorithm com-
pared to the traditional surveillance determinations (P p
for difference in k heterogeneity). There was significant.04
heterogeneity among the k values for the traditional surveil-
lance/audit review (range, 0.22–0.62; ), whereas k val-P p .01
ues for the computer algorithm/audit review were homoge-
neous (range, 0.48–0.67; ; Figure 2).P p .80
Relationship between Performance (Audit Agreement)
and Central Line–Associated BSI Rates
For traditional surveillance, we found a dependent relation-
ship between performance (agreement with audit review) and
central line–associated BSI rates (linear regression, slope p
; ; ; Figure 3A). ICUs with lower tra-20.16 r p 0.77 P p .001
ditional central line–associated BSI rates were associated with
poorer agreement with the audit review; conversely, ICUs
with higher traditional central line–associated BSI rates had
better agreement with audit review.
In contrast, the computer algorithm performance was sta-
ble and independent of the algorithm-defined central line–
associated BSI rate for ICUs ( ; ;2slope p 0.00 r p 0.88
; Figure 3B). The slopes of the respective linear mod-P p .86
els for traditional surveillance and computer algorithm sur-
veillance (Figure 3) were significantly different ( ).P p .001
discussion
In this multicenter study, we found that computer algorithm
detection of central line–associated BSI performed better than
traditional surveillance. With retrospective audit as a com-
parator, the computer algorithm had better overall agreement
across ICUs. Importantly for interfacility benchmarking and
public reporting, computer algorithmic detection resulted in
a consistent level of agreement with the audit review across
ICUs, independent of the algorithmic central line–associated
BSI rate reported. For traditional surveillance, we found in-
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figure 3. Relationship between performance of central line–associated bloodstream infection (CLABSI) surveillance (k) and CLABSI rates
at intensive care units, by surveillance method. Shaded regions represent the 95% confidence intervals around the fitted lines. A, Traditional
surveillance. B, Computer algorithm surveillance.
consistent performance, as evidenced by variation in tradi-
tional surveillance agreement with the audit review across
ICUs. Of particular concern, ICUs with lower (more favor-
able) traditional central line–associated BSI rates had worse
agreement with the audit review, indicating that lower central
line–associated BSI rates may be explained at least in part by
variability in surveillance rather than simply differences in
infection rates.
Evidence of significant facility-level variability in central
line–associated BSI surveillance has been previously described
in an ecologic study by Lin et al9 comparing ICU-level BSI
surveillance rates against an objective reference standard. A
subsequent study by Mayer et al7 of traditional central line–
associated BSI surveillance found that, when multiple infec-
tion preventionists reviewed identical patient records, only
55% uniformly agreed with each other (overall ).k p 0.42
Furthermore, with respect to reviewing identical sets of pa-
tient records, infection preventionists reported a wide range
of central line–associated BSI rates (14%–39% of records re-
viewed), whereas a laboratory-based definition mimicking the
current computer algorithm detected consistent central line–
associated BSI rates (range, 36%–42%). Our current study,
which confirms in a multifacility setting that traditional cen-
tral line–associated BSI surveillance performs inconsistently
when compared with audit review, fills a critical knowledge
gap by demonstrating that computer algorithm surveillance
performs more accurately and reliably across facilities.
Potential sources of variation in traditional surveillance
have been recognized. First, the central line–associated BSI
surveillance definition used during the study period (as well
as currently) inherently requires some subjective judgment,
particularly with respect to whether the primary source of a
positive blood culture is from a vascular or extravascular
infection site.14 Second, hospitals vary in their access to in-
fection preventionist staffing, expertise, or informatics re-
sources, which can lead to differences in surveillance inten-
sity.15,16 Third, as hospitals enforce greater scrutiny over
central line–associated BSI rates, the threshold for classifying
a true central line–associated BSI may be raised for infection
preventionists as well as for physicians or quality committees
who may be internally involved in reviewing individual BSI
cases.17-19 Efforts to decrease variation in surveillance practice
and improve sensitivity of central line–associated BSI detec-
tion have focused on the use of retrospective audits, which
are increasingly employed through state and territorial health
departments.10,20 Such audits have found variable sensitivity
in central line–associated BSI reporting.18,20,21 Continued val-
idation efforts may increase the accuracy of traditional sur-
veillance; however, such efforts are costly, resource intensive,
and difficult to sustain broadly.
For purposes of public reporting or performance mea-
surement, computer algorithms can provide an efficient and
reliable alternative to traditional surveillance of central line–
associated BSIs, especially as hospital data becomes increas-
ingly accessible electronically. Despite lacking subjective hu-
man judgment, this study and others suggest that use of
computer algorithms does not degrade accuracy.13 Impor-
tantly, a simulation study demonstrated that, even if accuracy
is compromised through use of objective criteria, the en-
hanced reliability results in more accurate rankings of hos-
pital-specific infection rates.12
There are practical barriers to implementing computer al-
gorithms for infection surveillance. First, in this study and
in others,9,22 computer algorithm–derived infection rates are
generally higher than traditional surveillance infection rates;
thus, meaningful interinstitution comparisons of rates would
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require that institutions be compared with others using the
same surveillance strategy. Second, computer algorithm sur-
veillance requires that hospitals store medical information,
such as microbiology laboratory results, in a manner available
for computer analysis; this is currently not universally avail-
able. Third, like any diagnostic test method, the positive pre-
dictive value of the algorithms will decrease as the true disease
prevalence is reduced. To assess generalizability, the perfor-
mance of computer algorithm surveillance would need to be
evaluated over a broader range of ICUs with varying degrees
of BSI burden.
Our study has several limitations. First, audit review at
each institution was performed internally by a blinded in-
dividual from the same institution. Although the audit review
was enhanced by a prereview training session and provision
of a step-wise surveillance worksheet to adhere to NHSN
surveillance standards, it is possible that the individual shared
similar judgment patterns with colleagues performing in the
traditional surveillance arm. Such a bias would have favored
agreement between traditional surveillance and audit review,
yet we found agreement that favored computer algorithm
surveillance over traditional surveillance. Second, audit re-
view, like computer algorithm surveillance, was performed
retrospectively and thus limited to documented medical in-
formation, whereas traditional surveillance was performed
prospectively and potentially enhanced through incorpora-
tion of unwritten clinical information obtained through dis-
cussion with clinical staff. However, NHSN surveillance cri-
teria do not explicitly incorporate clinician opinion into BSI
surveillance decision-making, and such information may be
a source of variability or bias.16,23 Lastly, we were not able to
qualitatively assess reasons for disagreement between tradi-
tional surveillance and audit review, because for the tradi-
tional surveillance review, we had no retained record of the
decision making process.
Computer algorithm surveillance can improve the reli-
ability and accuracy of central line–associated BSI surveil-
lance, enhancing the credibility of one of the most important
measures of hospital-acquired infection. Furthermore, in-
creased automation of hospital infection surveillance can fa-
vorably shift hospital infection control resources from count-
ing infections to preventing infections. Wide-scale adoption
of the computer algorithm in a consistent and verifiable man-
ner across reporting sites will be feasible in the future as
clinical data become standardized.11,24 Healthcare and public
health leaders should continue to support capacity building
and further evaluation of automated methods of healthcare-
associated infection detection.
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